Skip to Main Content

Paper Details

Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate Cancer.
Nat Cancer
47
2021
CRPC, CXCL10, ESK981, PIKfyve, Prostate Cancer, T cell, advanced prostate cancer, castration-resistant prostate cancer, interferon gamma, lipid, patients, tumor, tumors, tyrosine, tyrosine kinase
Author NameAffiliation
Xuhong CaoMichigan Center for Translational Pathology, University of Michigan ann arbor
Xuhong CaoHoward Hughes Medical Institute, University of Michigan ann arbor
Javed SiddiquiMichigan Center for Translational Pathology, University of Michigan ann arbor
Nora M NavoneThe University of Texas MD Anderson Cancer Center
Elisabeth I HeathKarmanos Cancer Institute, Wayne State University School of Medicine
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanRogel Cancer Center, University of Michigan ann arbor
Arul M ChinnaiyanHoward Hughes Medical Institute, University of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanRogel Cancer Center, University of Michigan ann arbor
Arul M ChinnaiyanHoward Hughes Medical Institute, University of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
  • 1 - 15

Datasets

Release 1.2